Found 36 results

2010
ADVANCE Collaborative Group, Writing Committee, Kengne AP, Patel A, Colagiuri S, Heller S, Hamet P, Marre M, Pan CY, Zoungas S et al..  2010.  The Framingham and UK Prospective Diabetes Study (UKPDS) risk equations do not reliably estimate the probability of cardiovascular events in a large ethnically diverse sample of patients with diabetes: the Action in Diabetes and Vascular Disease: Preterax. Diabetologia. Epub. [IF 6.418]
2009
Chow CK, Celermajer D, Joshi R , Patel A, Neal B.  2009.  Re-calibration of a Framingham Risk Equation for a Rural Population in India. Journal of Epidemiology and Community Health. 63:379-85[IF2.9].
CPACS Investigators, Writing Committee, Bi Y, Gao R, Patel A, Su S, Gao W, Hu D, Huang D, Kong L et al..  2009.  Evidence-based medication use among Chinese patients with acute coronary syndromes at the time of hospital discharge and 1 year after hospitalization: results from the Clinical Pathways for Acute Coronary Sydromes in China (CPACS) study. Am Heart J. 157:509-516.[IF3.649].
Wan Q, Harris MF, Zwar N, Campbell T, Patel A, Vagholkar S, McKenzie S, Walker C, Denney-Wilson E.  2009.  Study protocol for a randomized controlled trial: the feasibility and impact of cardiovascular absolute risk assessment in Australian general practice . Am Heart J . 157:436-441.[IF3.649].
Patel A, Chalmers J, Macmahon S, Neal B.  2009.  ADVANCE Blood pressure lowering in diabetes - Letter to the Editor. J Clin Hypertens (Greenwich). 11:108.[IF0].
ADVANCE Collaborative Group, Writing Committee, Ninomiya T, Perkovic V, de Galan B, Zoungas S, Pillai A, Jardine M, Patel A, Cass A et al..  2009.  Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes. J Am Soc Nephrol. 20:1813-21.[IF7.111]..
Zoungas S, Chalmers J, Patel A.  2009.  Cardiovascular risk in Type 2 diabetes . reflecting on the ADVANCE study. US Endocrinology. 5:95-9.[IF0.000].
Zoungas S, Chalmers J, Patel A.  2009.  Cardiovascular risk in Type 2 diabetes . reflecting on the ADVANCE study. Review. European Endocrinology. 5:42-46.[IF0.000].
Turnbull F, Arima H, Heeley E, Peiris D, Weekes A, Morgan C, Cass A, Anderson C, Patel A, Chalmers J.  2009.  Cardiovascular risk management among female and male patients in Australian General Practice: the AusHEART study. Proceedings of the 57th Annual Scientific Meeting of the Cardiac Society of Australia and New Zealand. <i>Heart, Lung and Circulation</i>. 2009;8(Suppl 3):S272
Heeley E, Peiris D, Patel A, Cass A, Weekes A, Morgan C, Anderson C, Chalmers J.  2009.  Cardiovascular risk perception and the evidence practice gap in Australian General Practice (the AusHEART study). Medical Journal of Australia. In press. [IF 3.320]
Patel A.  2009.  Cardiovascular risk . who should we treat and how much should we stratify. Heart. 95:783-4.[IF4.141]..
ADVANCE Collaborative Group, de Galan BE, Zoungas S, Chalmers J, Anderson C, Dufouil C, Pillai A, Cooper M, Grobbee DE, Hackett M et al..  2009.  Cognitive function and risks of cardiovascular disease and hypoglycaemia in people with type 2 diabetes; the ADVANCE trial. Diabetelogia. 52:2329-36.[IF6.418].
ADVANCE Collaborative Group, Writing Committee, Zoungas S, de Galan BE, Ninomiya T, Grobbee D, Hamet P, Heller S, Macmahon S, Marre M et al..  2009.  The combined effects of routine blood pressure lowering and intensive glucose control on macrovascular and microvascular outcomes in patients with type 2 diabetes; new results from ADVANCE. Diabetes Care. 32:2068-74.[IF7.349].
Heeley E, Peiris D, Weekes A, Morgan C, Cass A, Anderson C, Patel A, Chalmers J.  2009.  Current prescribing of Blood Pressure lowering and statin therapies in Australian general practice according to risk level using new guidelines for cardiovascular risk assessment. Proceedings of the 57th Annual Scientific Meeting of the Cardiac Society of Australia and New Zealand. <i>Heart, Lung and Circulation</i>. 2009;18(Suppl 3):S280
Obesity in Asia Collaboration, (Writing Committee), Barzi F , Woodward M, Czernichow S , Ying Lee CM, Kang JH, Janus E, Lear S, Patel A et al..  2009.  The discrimination of dyslipidaemia using anthropometric measures in ethnically diverse populations of the Asia Pacific Region: The Obesity in Asia Collaboration. Obesity Reviews . Epub. [IF 5.569].
AdRem Project Team and ADVANCE Management Committee, [Writing Committee], Beulens JWJ, Patel A, Vingerling JR, Cruickshank JK, Hughes AD, Stanton A, Lu J, McG Thom SA et al..  2009.  Effects of blood pressure lowering and intensive glucose control on incidence and progression of retinopathy in patients with type 2 diabetes mellitus: a randomised controlled trial. Diabetologia. 52:2027-36.[IF5.822].
Peiris D, Joshi R , Webster R, Groenestein P, Usherwood T, Heeley E, Turnbull F, Lipman A, Patel A.  2009.  An electronic clinical decision support tool to assist primary care providers in cardiovascular disease risk management: development and mixed methods evaluation. Journal of Medical Internet Research. 11:e51.[IF3.600].
Webster R, Heeley E, Bayram C, Peiris D, Cass A, Patel A.  2009.  Gaps in cardiovascular disease risk management in Australian general practice. Medical Journal of Australia. 191:324-9.[IF3.320].
Chow CK, Patel A.  2009.  A global view of cardiovascular risk factors. Therapeutic Strategies in Lipid Disorders.
Patel A, Peiris D, Groenestein P.  2009.  How to Treat . Cardiovascular Disease Risk Assessment. Australian Doctor. In press. [IF 0].
Webster R, Bayram C, Turnbull F, Patel A.  2009.  Management of cardiovascular risk factors in Australian General Practice of those at highest risk. Australasian Epidemiologist. 16:6-11.[IF0.000].
Peiris D, Joshi R , Webster R, Groenestein P, Usherwood T, Heeley E, Turnbull F, Lipman A, Patel A.  2009.  A novel electronic decision support system to assist general practitioners in cardiovascular disease risk management . a pilot evaluation. Proceedings of the 57th Annual Scientific Meeting of the Cardiac Society of Australia and New Zealand. Heart, Lung and Circulation. 2009;18(Suppl 3):S269
Heeley E, Peiris D, Weekes A, Cass A, Anderson C, Patel A, Chalmers J.  2009.  Prescribing of secondary prevention measures in Australian General Practice is lower in patients following an ischaemic stroke compared to those with a previous myocardial infarction. 6th Asia Pacific Conference Against Stroke.
Heeley E, Peiris D, Weekes A, Cass A, Anderson C, Patel A, Chalmers J.  2009.  Prescribing of secondary prevention measures in Australian General Practice is lower in patients following an ischaemic stroke compared to those with a previous myocardial infarction. Proceedings of the 57th Annual Scientific Meeting of the Cardiac Society of Australia and New Zealand. <i>Heart, Lung and Circulation</i>. 2009;18(Suppl 3):S280
ADVANCE Collaborative Group, Du X, Ninomiya T, de Galan B, Abadir E, Chalmers J, Pillai A, Woodward M, Cooper M, Harrap S et al..  2009.  Risk of cardiovascular events and effects of routine blood pressure lowering among patients with type 2 diabetes and artrial fibrillation . results of the ADVANCE study. Eur Heart J. 30 :1128-35.[IF7.924]..

Latest News

Recently added pages

Our focus

George Institute sites